Evidence map›Paper›PMID 38185665›Full record

ArticleBMC medicine2024

Benefits and challenges experienced by participants on long-term methadone maintenance treatment in China: a qualitative study.

Xijia Tang, Wenxue Xiong, Wen Chen, Chijie Wang, Hexuan Wang, Boyu Li, Zirong Zhang, Li Ling

Open access · goldAbstract read
In one paragraph

Article in BMC medicine, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.5field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 4 citations in OpenAlex.

  1. Article
  2. Article
  3. Mortality in methadone poisoning: a decade-long analysis of clinical predictors in an Iranian cohort.International journal of physiology, pathophysiology and pharmacology · 2026
    Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Xijia TangDepartment of Medical Statistics, School of Public Health, Sun Yat-Sen University, No.74 Zhongshan 2Nd Road, Yuexiu District, Guangzhou, Guangdong, PR China, 510080.
Wenxue XiongDepartment of Medical Statistics, School of Public Health, Sun Yat-Sen University, No.74 Zhongshan 2Nd Road, Yuexiu District, Guangzhou, Guangdong, PR China, 510080.
Wen ChenDepartment of Medical Statistics, School of Public Health, Sun Yat-Sen University, No.74 Zhongshan 2Nd Road, Yuexiu District, Guangzhou, Guangdong, PR China, 510080.
Chijie WangDepartment of Medical Statistics, School of Public Health, Sun Yat-Sen University, No.74 Zhongshan 2Nd Road, Yuexiu District, Guangzhou, Guangdong, PR China, 510080.
Hexuan WangDepartment of Medical Statistics, School of Public Health, Sun Yat-Sen University, No.74 Zhongshan 2Nd Road, Yuexiu District, Guangzhou, Guangdong, PR China, 510080.
Boyu LiDepartment of Medical Statistics, School of Public Health, Sun Yat-Sen University, No.74 Zhongshan 2Nd Road, Yuexiu District, Guangzhou, Guangdong, PR China, 510080.
Zirong ZhangSchool of Mathematics, Sun Yat-Sen University, Guangzhou, Guangdong, PR China.
Li LingDepartment of Medical Statistics, School of Public Health, Sun Yat-Sen University, No.74 Zhongshan 2Nd Road, Yuexiu District, Guangzhou, Guangdong, PR China, 510080. lingli@mail.sysu.edu.cn.
Sun Yat-sen University · CNSun Yat-sen Memorial Hospital · CN

Funding

National Natural Science Foundation of China 82073664
6 · The paper itself

Abstract

backgroundMethadone maintenance treatment (MMT) has been implemented in China for nearly two decades, with a significant decrease in the number of participants in recent years. However, there is a lack of comprehensive research focusing on the long-term effectiveness in the context of this decline, especially from the perspectives of MMT participants themselves. This study aims to address this gap by examining the benefits and challenges experienced by long-term MMT participants in China, to uncover potential causes of the decrease in participant numbers and to improve the effectiveness of the program.

methodsWe conducted semi-structured interviews with 21 long-term MMT participants (treatment duration ≥ 5 years) recruited through purposive sampling from 6 MMT clinics in the Guangdong Province, China, between December 2021 and August 2022. Thematic analysis was employed to analyze the transcribed interviews. Two analysts independently coded the data, and a third researcher double-coded 20% of transcripts to ensure intercoder reliability.

resultsOverall, participants corroborated the notable decline in MMT participants during their long-term MMT, citing death, arrest, and self-perceived abstinence from heroin, as their perceived driving factors. They reported positive changes in their health, family relationships, and social functioning. However, they identified economic hardship as their greatest challenge associated with MMT, further exacerbated by other barriers including the conflict of clinic opening hours and working schedules, discrimination from employers, and COVID-19-related restrictions. Additionally, participants identified issues with dose adjustment and emergency treatment continuation.

conclusionsThis study outlines the overall improvement in the quality of life of long-term MMT participants. However, it highlights the need for official guidelines for dose adjustment and emergency treatment continuation as well as the provision of health education, job referrals, and flexibility of clinic opening times to facilitate the return to society receiving participants. Establishing a follow-up mechanism for those receiving MMT is also recommended to prevent relapses to heroin and other illicit substances.

Indexed as

HeroinQuality of LifeChinaHumansMethadoneReproducibility of ResultsHeroinMethadoneBenefitsChallengesChinaLong-term retentionMethadone maintenance treatmentQualitative study

Identifiers

PMID38185665
PMCPMC10773040
OpenAlexW4390655811

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.